The interim data was the first to come from the Phase III DELIVER clinical trial, which compared the safety of the dapivirine vaginal ring and oral Truvada for the prevention of HIV in women during pregnancy. The participants were randomized two to one to use either the dapivirine vaginal ring or daily oral PrEP. One of the preterm births was in the vaginal ring arm and two were in the oral PrEP arm. None of those were deemed related to either the dapivirine ring or oral PrEP. He was also an investigator in earlier trials of the dapivirine ring, ASPIRE and HOPE.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.